dr. sherman on the role of regorafenib in liver cancer
Published 7 years ago • 229 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
2:21
dr. sherman on screening obstacles in liver cancer
-
1:08
dr. bendell on fda approval of regorafenib in liver cancer
-
1:04
dr. eckhardt on the role of regorafenib in colorectal cancer
-
5:31
practical advice for using regorafenib
-
9:34
regorafenib in colorectal cancer
-
1:16
dr. eng on roles of regorafenib and tas-102 in crc treatment
-
16:35
dr. finn on regorafenib for the treatment for patients with hcc
-
7:46
clinical use of regorafenib in mhcc
-
1:11
regorafenib vs sorafenib in the treatment of liver cancer
-
1:47
dr. jordi bruix on the impact regorafenib will have on liver cancer treatment
-
1:19
dr. kennedy on importance of sirflox study in liver-metastatic crc
-
0:49
dr. daniele on impact of regorafenib in hcc
-
3:06
dr. finn on tivantinib and regorafenib for the treatment of liver cancer
-
1:28
dr. overman on distinctions between regorafenib and tas-102 in crc
-
1:34
dr. finn on the promise of regorafenib for the treatment of hcc
-
0:58
dr. abou-alfa on significance of resorce trial for hcc
-
0:42
dr. bendell on the future of regorafenib for patients with crc
-
4:14
the use of regorafenib in clinical practice
-
3:14
when you have decided to prescribe regorafenib